Management of optic neuritis and impact of clinical trials: An international survey
Authors:
- Valérie BiousseVBValérie Biousse
- Olivier CalvettiOCOlivier Calvetti
- Carolyn D. Drews-BotschCDCarolyn D. Drews-Botsch
- Edward J. AtkinsEAEdward J. Atkins
- Busaba SathornsumeteeBSBusaba Sathornsumetee
- Nancy J. NewmanNNNancy J. Newman
- 1 January 2009
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 276 (1-2) , 69-74
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Multiple Sclerosis Risk After Optic NeuritisArchives of Neurology, 2008
- Visual Function 15 Years after Optic NeuritisOphthalmology, 2008
- T2 clinical research: Judgment dayAnnals of Neurology, 2008
- Corticosteroids for treating optic neuritis2007
- Evolving Management of Optic Neuritis and Multiple SclerosisAmerican Journal of Ophthalmology, 2005
- High- and Low-Risk Profiles for the Development of Multiple Sclerosis Within 10 Years After Optic NeuritisArchives of Ophthalmology (1950), 2003
- Practice parameter: The role of corticosteroids in the management of acute monosymptomatic optic neuritis [RETIRED]Neurology, 2000
- What We Have Learned from the Optic Neuritis Treatment TrialOphthalmology, 1995
- The Effect of Corticosteroids for Acute Optic Neuritis on the Subsequent Development of Multiple SclerosisNew England Journal of Medicine, 1993
- A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic NeuritisNew England Journal of Medicine, 1992